Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Oncotarget|December 17, 2021
Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomasRobert Hsu, Yasmine Baca, Joanne Xiu, et al.Plos One|May 2, 2013
Increased expression of pregnancy up-regulated non-ubiquitous calmodulin kinase is associated with poor prognosis in clear cell renal cell carcinomaSong Wu, Zhaojie Lv, Yong Wang, et al.Journal for Immunotherapy of Cancer|March 26, 2022
Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapyXin Liu, Yixiang Xu, Wei Xiong, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2021
<sup>64</sup>Cu-labeled daratumumab F(ab')<sub>2</sub> fragment enables early visualization of CD38-positive lymphomaLei Kang, Cuicui Li, Qi Yang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 24, 2021
CD38-Targeted Theranostics of Lymphoma with <sup>89</sup>Zr/<sup>177</sup>Lu-Labeled DaratumumabLei Kang, Cuicui Li, Zachary T Rosenkrans, et al.BMC Cancer|November 20, 2014
Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinomaSong Wu, Jiahao Chen, Pei Dong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent GlioblastomaJethro L Hu, Oluwaseun A Omofoye, Jeremy D Rudnick, et al.The Journal of Clinical Investigation|January 17, 2013
Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesisXiaojie Xu, Zhongyi Fan, Lei Kang, et al.Journal of Neurosurgery|September 17, 2022
ZEB1 loss increases glioma stem cell tumorigenicity and resistance to chemoradiationGeorge K Hanna, Mecca Madany, Angelique Sao-Mai Sy Tay, et al.Proceedings of the National Academy of Sciences of the United States of America|July 26, 2020
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathologyXiao He, Alison W Ashbrook, Yang Du, et al.Pageof 8